<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pathology of relapsing polychondritis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pathology of relapsing polychondritis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pathology of relapsing polychondritis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marcela A Ferrada, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jane Hoyt Buckner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Philip Seo, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 28, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Relapsing polychondritis (RPC) is characterized by widespread, potentially destructive, inflammatory, and degenerative lesions.</p><p>While ear cartilage involvement has been classically associated with RPC, the disease may involve cartilage and biochemically and immunologically related connective tissue structures throughout the body  (<a class="graphic graphic_table graphicRef76071" href="/d/graphic/76071.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/5606.html" rel="external">"Clinical manifestations of relapsing polychondritis"</a>.)</p><p>This topic will review the pathologic changes associated with RPC. The pathogenesis of this disorder is discussed separately. (See  <a class="medical medical_review" href="/d/html/5604.html" rel="external">"Etiology and pathogenesis of relapsing polychondritis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">HISTOLOGY OF A TYPICAL ACTIVE EAR LESION</span><span class="headingEndMark"> — </span>Biopsy findings of an active ear lesion can be representative of pathologic changes occurring at connective tissue sites elsewhere. There is a characteristic spectrum of changes that depends upon the time the biopsy is performed.</p><p class="bulletIndent1"><span class="glyph">●</span>A pleomorphic perichondral infiltrate of lymphocytes with a variable proportion of polymorphonuclear cells, monocyte/macrophages, and plasma cells is initially observed at the chondro-dermal junction  (<a class="graphic graphic_picture graphicRef68917" href="/d/graphic/68917.html" rel="external">picture 1</a>). Lymphocytes dominate with CD4 helper T cells exceeding CD8 cytotoxic T cells [<a href="#rid1">1</a>]. Contiguous regions of cartilage show evidence of proteoglycan depletion. Coarse granular deposits consisting primarily of immunoglobulin G (IgG) and C3 can be localized by direct immunofluorescence at the junctional site.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>As the disease progresses, the integrity of cartilage is disrupted by invading granulation tissue, which tends to sequester islands of degenerating chondrocytes and depleted matrix  (<a class="graphic graphic_picture graphicRef55022" href="/d/graphic/55022.html" rel="external">picture 2</a>). IgG and C3 may be seen throughout the matrix. Matrix metalloproteinases (MMP) are expressed in both the perichondral granulation tissue and chondrocytes [<a href="#rid2">2</a>]. Chondrocyte apoptosis is increased in chondritis lesions and correlates with the expression of MMP-3 and cathepsin-K. Nitric oxide expression is increased, reflecting the chondrocyte production of pro-apoptotic MMPs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The late stage of the disease is characterized by complete disruption of tissue architecture and fibrosis  (<a class="graphic graphic_picture graphicRef80944" href="/d/graphic/80944.html" rel="external">picture 3</a>). Gelatinous cysts may be observed with focal regions of calcification and bone formation.</p><p></p><p>Electron microscopy shows prominent chondrocyte cytoplasmic processes extending into regions of damage [<a href="#rid3">3</a>]. These contain as-yet-to-be-identified small, electron-dense granules and vesicles of varying size, shape, and density.</p><p>The chondrocytes appear to be actively phagocytosing degraded material and are rich in lysosomes, lipid, and glycogen. Collagen and elastic fibers are eventually destroyed. Finely granular electron-dense material may be seen coating such fibers and may be on the surface of cartilage.</p><p class="headingAnchor" id="H3"><span class="h1">PATHOLOGY AT OTHER SITES</span><span class="headingEndMark"> — </span>Other anatomic areas and organs that may be involved include the eyes, inner ear, nose, upper and lower airway, vascular system, skin, joints, kidney, and nervous system  (<a class="graphic graphic_table graphicRef76071" href="/d/graphic/76071.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/5606.html" rel="external">"Clinical manifestations of relapsing polychondritis"</a>.)</p><p class="headingAnchor" id="H186725976"><span class="h2">Upper airway</span><span class="headingEndMark"> — </span>Several structures localized in the upper airway can be affected due to relapsing polychondritis (RPC), including vocal cords, arytenoids, epiglottis, and subglottic space [<a href="#rid4">4,5</a>]. Direct visualization during acute episodes demonstrates erythema and edema. Chronic inflammation may result in scarring of tissue, leading to subglottic stenosis [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H4124639274"><span class="h2">Lower airway</span><span class="headingEndMark"> — </span>During acute inflammation, tracheal and bronchial mucosa may be erythematous and edematous [<a href="#rid7">7</a>]. Over time, due to recurrent episodes of inflammation, the cartilaginous structures can collapse, causing tracheomalacia and bronchomalacia as well as tracheobronchial thickening, fibrosis, and calcifications [<a href="#rid8">8</a>]. Patients with RPC can also have distal airway inflammation leading to air trapping.</p><p>Histologic findings of inflamed trachea due to RPC are variable and can depend on the disease stage. Acutely, the inflammation is lymphocyte predominant with plasma cells, neutrophils, and eosinophils [<a href="#rid7">7,9</a>]. Fibrosis is seen in chronic inflammation [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H3692623809"><span class="h2">Aorta</span><span class="headingEndMark"> — </span>At sites of aortic involvement, the media appears vascularized, and there is lymphocyte cuffing of the vasa vasorum. Mononuclear cell infiltration occurs with depletion of glycosaminoglycan content and with subsequent fragmentation and destruction of collagen and elastic fibers. Inflammation may extend throughout the aortic wall [<a href="#rid10">10</a>]. Smooth muscle destruction may lead to aneurysm formation. The aortic ring may be dilated, and valve leaflets may be thickened or ruptured.</p><p class="headingAnchor" id="H6"><span class="h2">Synovia</span><span class="headingEndMark"> — </span>Synovial tissue biopsies have shown a chronic synovitis with edema and mononuclear cell infiltration.</p><p class="headingAnchor" id="H7"><span class="h2">Kidney</span><span class="headingEndMark"> — </span>Renal pathology is rare and variable in RPC because of its association with diverse autoimmune and connective tissue diseases and with immunoglobulin A (IgA) nephropathy  (<a class="graphic graphic_table graphicRef81401" href="/d/graphic/81401.html" rel="external">table 2</a>) [<a href="#rid11">11,12</a>]. As a result, renal involvement may reflect both RPC and the related diseases. Three major changes have been attributed to RPC [<a href="#rid11">11</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Mild mesangial matrix expansion and cell proliferation</p><p class="bulletIndent1"><span class="glyph">●</span>Segmental crescentic necrotizing glomerulonephritis</p><p class="bulletIndent1"><span class="glyph">●</span>Tubulointerstitial disease</p><p></p><p>Mesangial deposition of IgG, IgM, and/or C3 may be seen by immunofluorescent microscopy, correlating with electron microscopic evidence of electron-dense mesangial deposits. Variable degrees of vascular and glomerular sclerosis and of tubular loss have been observed at necropsy.</p><p class="headingAnchor" id="H8"><span class="h2">Eye</span><span class="headingEndMark"> — </span>In the eye, episcleral vessels may be surrounded by plasma cells, lymphocytes, and mast cells; there may also be a vasculitis with immunoglobulin deposition in scleral and conjunctival vessels [<a href="#rid13">13</a>]. These changes may be associated with loss of basophilia and fragmentation of elastic tissue at the scleroconjunctival angle. A case of RPC-manifesting chronic bilateral follicular conjunctivitis has been described, with conjunctival biopsy demonstrating a granulomatous obliterative microangiopathy with numerous eosinophils, plasma cells, lymphocytes, and epithelioid cells in the substantia propria [<a href="#rid14">14</a>]. The chronic conjunctivitis resolved following use of systemic <a class="drug drug_general" data-topicid="9630" href="/d/drug information/9630.html" rel="external">methotrexate</a>, indicating that such a presentation may be indicative of smoldering RPC and may be a harbinger of potential visceral disease.</p><p>Inflammatory cells may infiltrate the peripheral region of the cornea, which can show edema and necrotic changes. The iris may also be infiltrated with chronic inflammatory cells and may contain granulation tissue.</p><p>Optic neuropathy, an uncommon feature of RPC, has been attributed to ischemia, intrinsic inflammation of the optic nerve, or spread of inflammation to the nerve from adjacent intraconal orbital tissues. There is a description of optic neuropathy associated with periosteal thickening and enhancement in the apical orbit and in the adjacent intracranial space consistent with periostitis [<a href="#rid15">15</a>].</p><p class="headingAnchor" id="H3103903169"><span class="h2">Central nervous system</span><span class="headingEndMark"> — </span>In the brain, the inflammatory infiltrates are usually perivascular and consist of lymphocytes, plasma cells, and macrophages [<a href="#rid16">16,17</a>]. Patients with RPC can have limbic encephalitis, panencephalitis, and meningitis. Cerebrospinal fluid (CSF) examination findings include lymphocytic pleocytosis [<a href="#rid18">18-22</a>].</p><p class="headingAnchor" id="H9"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Relapsing polychondritis (RPC) is characterized by widespread, potentially destructive, inflammatory and degenerative lesions. Ear cartilage is classically affected, but RPC may involve cartilage and biochemically and immunologically related connective tissue structures throughout the body. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is a characteristic spectrum of pathologic changes that depends upon the duration of involvement at a given site. A pleomorphic perichondral infiltrate of lymphocytes with a variable proportion of polymorphonuclear cells, monocyte/macrophages, and plasma cells is initially observed at the chondro-dermal junction, along with coarse granular deposits consisting primarily of immunoglobulin (Ig) and complement. Contiguous regions of cartilage show evidence of proteoglycan depletion. (See <a class="local">'Histology of a typical active ear lesion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>As the disease progresses, the integrity of cartilage is disrupted by invading granulation tissue, which tends to sequester islands of degenerating chondrocytes and depleted matrix. Chondrocyte apoptosis related to increased expression of matrix metalloproteinases (MMPs) and nitric oxide are part of the primary process of cartilage damage. The late stage of the disease is characterized by complete disruption of tissue architecture and fibrosis. Gelatinous cysts may be observed with focal regions of calcification and bone formation. Collagen and elastic fibers are eventually destroyed. (See <a class="local">'Histology of a typical active ear lesion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>At sites of aortic involvement, the media appears vascularized, and there is lymphocyte cuffing of the vasa vasorum. Mononuclear cell infiltration occurs with depletion of glycosaminoglycan content and with subsequent fragmentation and destruction of collagen and elastic fibers. Inflammation may extend throughout the aortic wall. Smooth muscle destruction may lead to aneurysm formation. The aortic ring may be dilated, and valve leaflets may be thickened or ruptured. (See <a class="local">'Aorta'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The upper and lower airway mucosa may be edematous and erythematous. Chronic inflammation can lead to subglottic stenosis and tracheobronchomalacia. (See <a class="local">'Upper airway'</a> above and <a class="local">'Lower airway'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Synovial tissue biopsies have shown a chronic synovitis with edema and mononuclear cell infiltration. (See <a class="local">'Synovia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Renal pathology is variable in RPC because of its association with diverse autoimmune and connective tissue diseases and with IgA nephropathy. As a result, renal involvement may reflect both RPC and the related diseases. (See <a class="local">'Kidney'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the eye, episcleral vessels may be surrounded by plasma cells, lymphocytes, and mast cells; there may also be a vasculitis with immunoglobulin deposition in scleral and conjunctival vessels. These changes may be associated with loss of basophilia and with fragmentation of elastic tissue at the scleroconjunctival angle. Involvement of the conjunctiva, cornea, and iris may occur. Optic neuropathy is uncommon. (See <a class="local">'Eye'</a> above.)</p><p></p><p class="headingAnchor" id="H3210277240"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Clement J Michet, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Riccieri V, Spadaro A, Taccari E, Zoppini A. A case of relapsing polychondritis: pathogenetic considerations. Clin Exp Rheumatol 1988; 6:95.</a></li><li><a class="nounderline abstract_t">Ouchi N, Uzuki M, Kamataki A, et al. Cartilage destruction is partly induced by the internal proteolytic enzymes and apoptotic phenomenon of chondrocytes in relapsing polychondritis. J Rheumatol 2011; 38:730.</a></li><li><a class="nounderline abstract_t">Hashimoto K, Arkin CR, Kang AH. Relapsing polychondritis: an ultrastructural study. Arthritis Rheum 1977; 20:91.</a></li><li><a class="nounderline abstract_t">Kothari T, Valsamakis T, Sridhar AV, Ahmed MI. Case of paediatric relapsing polychondritis with severe airway involvement: the challenges of long-term airway and respiratory management. BMJ Case Rep 2021; 14.</a></li><li><a class="nounderline abstract_t">Dion GR, De la Chapa JS, Bettenhausen W, et al. Differing Progression to Posterior Glottic Stenosis in Autoimmune and Idiopathic Subglottic Stenosis. Laryngoscope 2021; 131:1816.</a></li><li><a class="nounderline abstract_t">Catano J, Uzunhan Y, Paule R, et al. Presentation, Diagnosis, and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory Diseases. Chest 2022; 161:257.</a></li><li><a class="nounderline abstract_t">Yanagihara T, Ohgushi M, Setoguchi T, et al. Early Recognition and Treatment of Relapsing Polychondritis. Cureus 2022; 14:e21463.</a></li><li><a class="nounderline abstract_t">Hoetzenecker K, Kollmann D, Schweiger T, et al. Unsuspected finding of a relapsing perichondritis during lung explantation. Ann Thorac Surg 2012; 94:1353.</a></li><li><a class="nounderline abstract_t">Winstanley S, Boyde A, Attanoos R. Fatal relapsing tracheobronchial polychondritis diagnosed at autopsy. BMJ Case Rep 2015; 2015.</a></li><li><a class="nounderline abstract_t">Selim AG, Fulford LG, Mohiaddin RH, Sheppard MN. Active aortitis in relapsing polychondritis. J Clin Pathol 2001; 54:890.</a></li><li><a class="nounderline abstract_t">Chang-Miller A, Okamura M, Torres VE, et al. Renal involvement in relapsing polychondritis. Medicine (Baltimore) 1987; 66:202.</a></li><li><a class="nounderline abstract_t">Dalal BI, Wallace AC, Slinger RP. IgA nephropathy in relapsing polychondritis. Pathology 1988; 20:85.</a></li><li><a class="nounderline abstract_t">Hoang-Xaun T, Foster CS, Rice BA. Scleritis in relapsing polychondritis. Response to therapy. Ophthalmology 1990; 97:892.</a></li><li><a class="nounderline abstract_t">Yu EN, Jurkunas U, Rubin PA, et al. Obliterative microangiopathy presenting as chronic conjunctivitis in a patient with relapsing polychondritis. Cornea 2006; 25:621.</a></li><li><a class="nounderline abstract_t">Hirunwiwatkul P, Trobe JD. Optic neuropathy associated with periostitis in relapsing polychondritis. J Neuroophthalmol 2007; 27:16.</a></li><li><a class="nounderline abstract_t">Niwa A, Okamoto Y, Kondo T, et al. Perivasculitic panencephalitis with relapsing polychondritis: an autopsy case report and review of previous cases. Intern Med 2014; 53:1191.</a></li><li><a class="nounderline abstract_t">Ellis RJB, Doran M, Jacob A, et al. Clinicopathological case: rapid cognitive decline and myoclonus associated with fever, arthropathy and scleritis. Pract Neurol 2019; 19:147.</a></li><li><a class="nounderline abstract_t">Brucki SM, Rocha MS. [Relapsing polychondritis associated with meningoencephalitis: case report]. Arq Neuropsiquiatr 2001; 59:605.</a></li><li><a class="nounderline abstract_t">Cao J, Zhang M. Pleocytosis in a patient with relapsing polychondritis accompanied by meningoencephalitis: a case report. BMC Neurol 2018; 18:53.</a></li><li><a class="nounderline abstract_t">Kao KT, Potrebic S, Evans JR. Relapsing polychondritis presenting as meningoencephalitis with valvular abnormality: a case report. Clin Rheumatol 2007; 26:1985.</a></li><li><a class="nounderline abstract_t">Matsumoto H, Tokimura R, Fujita Y, et al. Meningoencephalitis in relapsing polychondritis: A case report. Medicine (Baltimore) 2021; 100:e26315.</a></li><li><a class="nounderline abstract_t">Kondo T, Fukuta M, Takemoto A, et al. Limbic encephalitis associated with relapsing polychondritis responded to infliximab and maintained its condition without recurrence after discontinuation: a case report and review of the literature. Nagoya J Med Sci 2014; 76:361.</a></li></ol></div><div id="topicVersionRevision">Topic 5621 Version 16.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3396253" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A case of relapsing polychondritis: pathogenetic considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21239745" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Cartilage destruction is partly induced by the internal proteolytic enzymes and apoptotic phenomenon of chondrocytes in relapsing polychondritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/836341" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Relapsing polychondritis: an ultrastructural study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34380670" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Case of paediatric relapsing polychondritis with severe airway involvement: the challenges of long-term airway and respiratory management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32902896" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Differing Progression to Posterior Glottic Stenosis in Autoimmune and Idiopathic Subglottic Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34324839" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Presentation, Diagnosis, and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35223247" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Early Recognition and Treatment of Relapsing Polychondritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23006699" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Unsuspected finding of a relapsing perichondritis during lung explantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26347233" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Fatal relapsing tracheobronchial polychondritis diagnosed at autopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11684729" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Active aortitis in relapsing polychondritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3574118" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Renal involvement in relapsing polychondritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3287308" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : IgA nephropathy in relapsing polychondritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2381703" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Scleritis in relapsing polychondritis. Response to therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16783155" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Obliterative microangiopathy presenting as chronic conjunctivitis in a patient with relapsing polychondritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17414867" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Optic neuropathy associated with periostitis in relapsing polychondritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24881747" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Perivasculitic panencephalitis with relapsing polychondritis: an autopsy case report and review of previous cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30425126" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Clinicopathological case: rapid cognitive decline and myoclonus associated with fever, arthropathy and scleritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11588645" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : [Relapsing polychondritis associated with meningoencephalitis: case report].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29699514" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pleocytosis in a patient with relapsing polychondritis accompanied by meningoencephalitis: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17404785" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Relapsing polychondritis presenting as meningoencephalitis with valvular abnormality: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34128872" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Meningoencephalitis in relapsing polychondritis: A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25741046" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Limbic encephalitis associated with relapsing polychondritis responded to infliximab and maintained its condition without recurrence after discontinuation: a case report and review of the literature.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
